Jeffrey Landau
Corporate Officer/Principal en CYTOMX THERAPEUTICS, INC. .
Fortuna: 188 384 $ al 30/04/2024
Perfil
Jeffrey Landau is currently the Chief Business Officer, Senior VP & Head-Strategy at CytomX Therapeutics, Inc. He previously worked as the Vice President-Business Development at Catalyst Biosciences, Inc. from 2016 to 2021.
Prior to that, he was the Director-Corporate Development & Marketing at Threshold Pharmaceuticals, Inc. Mr. Landau has an undergraduate degree from Virginia Polytechnic Institute & State University and an MBA from Stanford Graduate School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/03/2024 | 117 740 ( 0.17% ) | 188 384 $ | 30/04/2024 |
Cargos activos de Jeffrey Landau
| Empresas | Cargo | Inicio |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2021 |
Antiguos cargos conocidos de Jeffrey Landau.
| Empresas | Cargo | Fin |
|---|---|---|
| CATALYST BIOSCIENCES | Corporate Officer/Principal | 01/03/2021 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Ventas & Marketing | - |
Formación de Jeffrey Landau.
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey Landau
